Neuberger Berman Group’s Immunomedics Inc IMMU Stock Holding History

Neuberger Berman Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-68,803	Closed	-$5.79M	–	1770
2020 Q3	$5.79M	Buy	+68,803	New	+$3.48M	0.01%	832
2019 Q1	–	Sell	-78,685	Closed	-$1.12M	–	1645
2018 Q4	$1.12M	Sell	78,685 -1,000	-1%	-$19.9K	﹤0.01%	1096
2018 Q3	$1.66M	Buy	79,685 +37,000	+87%	+$876K	﹤0.01%	1078
2018 Q2	$1.01M	Buy	+42,685	New	+$858K	﹤0.01%	1229
2017 Q3	–	Sell	-47,685	Closed	-$421K	–	1662
2017 Q2	$421K	Buy	+47,685	New	+$335K	﹤0.01%	1343

Neuberger Berman Group's IMMU Position: Q4 2020 in Review

Neuberger Berman Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 68,803 shares — an estimated $5.79M sold.

Neuberger Berman Group first reported a position in IMMU in Q2 2017 and held it in 5 quarters. The position peaked at $5.79M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Neuberger Berman Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Neuberger Berman Group sold 68,803 Immunomedics Inc shares in Q4 2020, an estimated $5.79M.
Neuberger Berman Group first reported a position in Immunomedics Inc in Q2 2017 and held it in 5 quarters.
Neuberger Berman Group's Immunomedics Inc position peaked at $5.79M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Neuberger Berman Group's 13F filing for Q4 2020, filed 10 Feb 2021.